Jazz Pharmaceuticals PLC (JAZZ)
Days of sales outstanding (DSO)
| Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Receivables turnover | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| DSO | days | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
December 31, 2024 calculation
DSO = 365 ÷ Receivables turnover
= 365 ÷ —
= —
Based on the provided data, the days of sales outstanding (DSO) for Jazz Pharmaceuticals PLC are not available for the periods from March 31, 2020, to December 31, 2024.
DSO is a financial ratio that indicates the average number of days a company takes to collect revenue after a sale is made. A lower DSO value typically suggests that the company is efficient in collecting payments from its customers, while a higher value may indicate potential liquidity and cash flow challenges.
Without the specific DSO figures, it is challenging to perform a detailed analysis of Jazz Pharmaceuticals PLC's collection efficiency and working capital management over the periods specified. For a comprehensive evaluation of the company's financial performance and operational effectiveness, it would be necessary to have access to the actual DSO values or additional financial data to calculate and interpret this ratio.
Peer comparison
Dec 31, 2024